1Q 2023 Kemper Financial Supplement
Exhibit 99.2
Investor Supplement
First Quarter 2023
The financial statements and financial exhibits included herein are unaudited. This supplement recasts previously reported financial information for the provisions of Accounting Standards Update No. 2018-12, "Targeted Improvements to the Accounting for Long-Duration Contracts and related amendments" ("LDTI") adopted as of
with the Company's periodic reports on Forms 10-K,10-Q and 8-K filed with the
Caution Regarding Forward-Looking Statements
This Investor Supplement may contain or incorporate by reference information that includes or is based on forward-looking statements within the meaning of the safe- harbor provisions of the Private Securities Litigation Reform Act of 1995. We caution investors that these forward-looking statements are not guarantees of future performance, and actual results may differ materially. Such statements involve known and unknown risks, uncertainties, and other factors, including but not limited to:
- changes in the frequency and severity of insurance claims;
- claim development and the process of estimating claim reserves;
- the impacts of inflation;
- changes in the interest rate environment;
- supply chain disruption;
- product demand and pricing;
- effects of governmental and regulatory actions;
- litigation outcomes;
- investment risks;
- cybersecurity risks;
- impact of catastrophes; and
- other risks and uncertainties detailed in Kemper's Annual Report on Form 10-K and subsequent filings with the
Securities and Exchange Commission ("SEC").
Exhibit 99.2
Non-GAAP Financial Measures
This document contains non-GAAP financial measures to analyze the Company's operating performance for the periods presented. Because the Company's calculation of these measures may differ from similar measures used by other companies, investors should be careful when comparing the Company's non-GAAP financial measures to those of other companies. For detailed disclosures on non-GAAP financial measures please refer to the "Definitions of Non-GAAP Financial Measures" on pages 33-34.
|
|
Investor Supplement |
|
First Quarter 2023 |
|
Table of Contents |
|
Page |
|
Consolidated Impacts of Adoption of Targeted Improvements to Accounting for Long-Duration Contracts |
2 |
Consolidated Financial Highlights |
3 |
Consolidated Statements of Loss |
4 |
Consolidated Balance Sheets |
5 |
Consolidated Statements of Cash Flows |
6-7 |
Capital Metrics |
8-9 |
Debt Outstanding, FHLB Advances and Ratings |
10 |
Segment Summary Results: |
|
Revenues |
11 |
Operating Loss |
12 |
Net Operating Loss |
12 |
Catastrophe Frequency and Severity |
13 |
Specialty Property & Casualty Insurance Segment - Results of Operations and Selected Financial Information |
14-15 |
|
16 |
|
17 |
Preferred Property & Casualty Insurance Segment - Results of Operations and Selected Financial Information |
18-19 |
|
20 |
|
21 |
|
22 |
Other |
23 |
Life & Health Insurance Segment - Results of Operations and Selected Financial Information |
24 |
Life Insurance |
25 |
|
25 |
|
26 |
Expenses |
27 |
Details of Investment Performance |
28 |
Details of Invested Assets |
29-30 |
Investment Concentration |
31 |
|
32 |
Investments in Limited Liability Companies and Limited Partnerships |
33 |
Definitions ofNon-GAAPFinancial Measures |
34-35 |
Consolidated Impacts of Adoption of Targeted Improvements to Accounting for Long-Duration Contracts
(Dollars in Millions, Except Per Share Amounts)
(Unaudited)
The Company adopted LDTI on a modified retrospective basis as of
The following summarizes the increase (decrease) to earnings and earnings per share as a result of the adoption of LDTI.
For the Three Months Ended |
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||
2022 |
2022 |
2022 |
2022 |
2021 |
2021 |
2021 |
2021 |
||||||||||||||||
LDTI Impacts to Net Income (Loss) |
$ |
2.2 |
$ |
1.4 |
$ |
2.5 |
$ |
8.5 |
$ |
8.2 |
$ |
(4.0) |
$ |
(1.7) |
$ |
(5.7) |
|||||||
LDTI Impacts to Adjusted Consolidated Net Income |
|||||||||||||||||||||||
(Loss) |
$ |
2.2 |
$ |
1.4 |
$ |
2.5 |
$ |
8.5 |
$ |
8.2 |
$ |
(4.0) |
$ |
(1.7) |
$ |
(5.7) |
|||||||
LDTI Impact to Income (Loss) Per Unrestricted Share: |
|||||||||||||||||||||||
Basic - Net Income (Loss) |
$ |
0.03 |
$ |
0.02 |
$ |
0.04 |
$ |
0.13 |
$ |
0.13 |
$ |
(0.06) |
$ |
(0.03) |
$ |
(0.09) |
|||||||
Basic - Adjusted Consolidated Net Income (Loss) |
$ |
0.03 |
$ |
0.02 |
$ |
0.04 |
$ |
0.13 |
$ |
0.13 |
$ |
(0.06) |
$ |
(0.03) |
$ |
(0.09) |
|||||||
Diluted - Net Income (Loss) |
$ |
0.03 |
$ |
0.02 |
$ |
0.04 |
$ |
0.13 |
$ |
0.13 |
$ |
(0.06) |
$ |
(0.03) |
$ |
(0.09) |
|||||||
Diluted - Adjusted Consolidated Net Income (Loss) |
$ |
0.03 |
$ |
0.02 |
$ |
0.04 |
$ |
0.13 |
$ |
0.13 |
$ |
(0.06) |
$ |
(0.03) |
$ |
(0.09) |
For the Year Ended
|
|
|||
2022 |
2021 |
|||
$ |
14.6 |
$ |
(3.2) |
|
$ |
14.6 |
$ |
(3.2) |
|
$ |
0.22 |
$ |
(0.05) |
|
$ |
0.22 |
$ |
(0.05) |
|
$ |
0.22 |
$ |
(0.05) |
|
$ |
0.22 |
$ |
(0.05) |
The following summarizes the increase (decrease) to Shareholders' Equity as a result of the adoption of LDTI.
As of |
||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||||||||
2022 |
2022 |
2022 |
2022 |
2021 |
2021 |
2021 |
2021 |
2021 |
||||||||||||||||||
Retained Earnings |
$ |
(13.7) |
$ |
(15.9) |
$ |
(17.3) |
$ |
(19.8) |
$ |
(28.3) |
$ |
(36.5) |
$ |
(32.5) |
$ |
(30.8) |
$ |
(25.1) |
||||||||
Changes in the Discount Rate on Future Life |
||||||||||||||||||||||||||
Policyholder Benefits (AOCI) |
241.1 |
272.8 |
11.4 |
(405.5) |
(849.7) |
(823.9) |
(852.9) |
(626.1) |
(1,030.3) |
|||||||||||||||||
Increase (Decrease) in Shareholders' Equity |
$ |
227.4 |
$ |
256.9 |
$ |
(5.9) |
$ |
(425.3) |
$ |
(878.0) |
$ |
(860.4) |
$ |
(885.4) |
$ |
(656.9) |
$ |
(1,055.4) |
Consolidated Financial Highlights
(Dollars in Millions, Except Per Share Amounts)
(Unaudited)
For Period Ended
Earned Premiums.................................................................................................................................................................................................
Net Investment Income .......................................................................................................................................................................................
Change in Value of Alternative Energy Partnership Investments........................................................................................................................
Other Income .......................................................................................................................................................................................................
Income (Loss) from Change in Fair Value of
Net Realized Investment Gains (Losses) ..............................................................................................................................................................
Total Revenues.....................................................................................................................................................................................................
Net Loss................................................................................................................................................................................................................
Adjusted Consolidated Net Operating Loss1 ........................................................................................................................................................
Per Unrestricted Common Share Amounts:
Basic:
Net Loss ..........................................................................................................................................................................................................
Adjusted Consolidated Net Operating Loss1 ..................................................................................................................................................
Diluted:
Net Loss ..........................................................................................................................................................................................................
Adjusted Consolidated Net Operating Loss1 ..................................................................................................................................................
Dividends Paid to Shareholders Per Share...........................................................................................................................................................
At Period End
Total Assets ..........................................................................................................................................................................................................
Insurance Reserves ..............................................................................................................................................................................................
Debt......................................................................................................................................................................................................................
Shareholders' Equity ............................................................................................................................................................................................
Shareholders' Equity Excluding Goodwill1,2 .........................................................................................................................................................
Common Shares Issued and Outstanding (In Millions)........................................................................................................................................
Book Value Per Share2 .........................................................................................................................................................................................
Book Value Per Share Excluding Goodwill1,2 ........................................................................................................................................................
Book Value Per Share Excluding Net Unrealized (Gains) Losses on Fixed Maturities and Changes in the Discount Rate on Future Life
Policyholder Benefits1,2 ...................................................................................................................................................................................
Book Value Per Share Excluding Net Unrealized (Gains) Losses on Fixed Maturities, Changes in the Discount Rate on Future Life
Policyholder Benefits and
Debt to Total Capitalization2 ................................................................................................................................................................................
Rolling 12 Months Retuon5-pointAverage Shareholders Equity2,3 ...............................................................................................................
- Non-GAAPFinancial Measure. See page 34 for definition.
2 See Capital Metrics on pages 8-9 for detail calculations.
Three Months Ended |
|||||||||||||
|
|
|
|
|
|||||||||
2023 |
2022 |
2022 |
2022 |
2022 |
|||||||||
$ |
1,180.9 |
$ |
1,264.9 |
$ |
1,290.9 |
$ |
1,337.6 |
$ |
1,320.0 |
||||
101.8 |
106.3 |
97.8 |
118.5 |
100.0 |
|||||||||
0.7 |
1.3 |
0.4 |
(4.9) |
(16.7) |
|||||||||
1.2 |
1.9 |
4.0 |
0.9 |
2.4 |
|||||||||
1.7 |
- |
(11.2) |
(40.5) |
(28.2) |
|||||||||
8.5 |
0.2 |
(20.4) |
6.1 |
(7.4) |
|||||||||
$ |
1,294.8 |
$ |
1,374.6 |
$ |
1,361.5 |
$ |
1,417.7 |
$ |
1,370.1 |
||||
$ |
(80.1) |
$ |
(53.3) |
$ |
(74.8) |
$ |
(72.2) |
$ |
(86.3) |
||||
$ |
(65.2) |
$ |
(24.4) |
$ |
(29.1) |
$ |
(37.2) |
$ |
(51.6) |
||||
$ |
(1.25) |
$ |
(0.84) |
$ |
(1.17) |
$ |
(1.13) |
$ |
(1.36) |
||||
$ |
(1.02) |
$ |
(0.38) |
$ |
(0.46) |
$ |
(0.58) |
$ |
(0.81) |
||||
$ |
(1.25) |
$ |
(0.84) |
$ |
(1.17) |
$ |
(1.13) |
$ |
(1.36) |
||||
$ |
(1.02) |
$ |
(0.38) |
$ |
(0.46) |
$ |
(0.58) |
$ |
(0.81) |
||||
$ |
0.31 |
$ |
0.31 |
$ |
0.31 |
$ |
0.31 |
$ |
0.31 |
||||
$ |
13,403.7 |
$ |
13,313.6 |
$ |
13,399.9 |
$ |
13,964.2 |
$ |
14,667.7 |
||||
$ |
6,120.7 |
$ |
6,033.1 |
$ |
5,940.1 |
$ |
6,343.5 |
$ |
6,864.3 |
||||
$ |
1,387.5 |
$ |
1,386.9 |
$ |
1,386.4 |
$ |
1,385.8 |
$ |
1,385.2 |
||||
$ |
2,646.9 |
$ |
2,670.6 |
$ |
2,694.5 |
$ |
2,844.1 |
$ |
2,969.2 |
||||
$ |
1,346.6 |
$ |
1,370.3 |
$ |
1,395.7 |
$ |
1,532.1 |
$ |
1,657.2 |
||||
63.982 |
63.913 |
63.884 |
63.850 |
63.800 |
|||||||||
$ |
41.37 |
$ |
41.79 |
$ |
42.18 |
$ |
44.54 |
$ |
46.54 |
||||
$ |
21.05 |
$ |
21.44 |
$ |
21.85 |
$ |
24.00 |
$ |
25.97 |
||||
$ |
47.93 |
$ |
49.23 |
$ |
50.16 |
$ |
51.76 |
$ |
53.11 |
||||
$ |
27.61 |
$ |
28.88 |
$ |
29.83 |
$ |
31.21 |
$ |
32.55 |
||||
34.4 % |
34.2 % |
34.0 % |
32.8 % |
31.8 % |
|||||||||
(10.1)% |
(10.0)% |
(11.1)% |
(10.7)% |
(9.9)% |
- Rolling 12 Months Retuon 5-point Average Shareholders Equity is calculated by taking the last 12 months of Net Income (Loss) divided by the 5-point average Shareholders' Equity. The 5-point Average Shareholders' Equity is calculated by using a 5-point quarter average of Shareholders' Equity for the 12 month period.
3
Attachments
Disclaimer
We cannot pursue happiness if we're in fear for our lives
1Q 2023 Earnings Call Presentation
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News